Target intelligence / Profile preview

POTE ankyrin domain family member G (POTEG)

Target
POTEG
Molecular classification
Other, Ankyrin repeat domain protein, POTE family protein
01

Overview

POTE ankyrin domain family member G (POTEG) is a member of the human POTE gene family, which encodes proteins predominantly expressed in reproductive tissues such as prostate, ovary, testis, and placenta, as well as in various cancers[1][2][3]. POTEG features several ankyrin repeats and a C-terminal spectrin-like domain, and is thought to be involved in protein-protein and cell membrane interactions[3]. Functional studies indicate that POTEG acts as a pro-apoptotic factor: downregulation of POTEG results in decreased apoptosis and poorer prognosis in esophageal squamous cell carcinoma (ESCC)[1]. It appears to suppress tumorigenesis by arresting the cell cycle at the G1/S checkpoint, downregulating cyclin-dependent kinases (CDKs), and inhibiting metastasis by reducing epithelial-mesenchymal transition[1]. POTEG and other POTE family members may serve as biomarkers for disease progression in certain cancers, but there is no current evidence to suggest that POTEG itself is a therapeutic target, nor are there known drugs directly targeting it[1][2][3].

Other names
POTE-14POTE14POTE14alphaCT104.4A26C2
02

Biological functions

Apoptosis (pro-apoptotic function)Cell cycle regulationInhibition of epithelial-mesenchymal transitionProtein-protein and cell membrane interactions
03

Disease associations

Cancer (notably esophageal squamous cell carcinoma, breast cancer, and possibly others)
04

Biomarkers

Potential biomarker for prognosis in esophageal squamous cell carcinoma (downregulation associated with poor outcome)

Beyond the preview

Go deeper on POTE ankyrin domain family member G (POTEG).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on POTE ankyrin domain family member G (POTEG).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call